Ï㽶ÊÓƵ

Event

"Neural stem cells: from development to repair"

Wednesday, April 6, 2011 15:30
Stewart Biology Building 1205 avenue du Docteur-Penfield, Montreal, QC, H3A 1B1, CA

Department of Human Genetics Guest Lecture:

Wednesday, April 6, 2011 ~ 3:30pm
Stewart Biology Building Room W4/12

Title: "Neural stem cells: from development to repairâ€

Freda Miller, Ph.D.

Professor
University of Toronto
Hospital for Sick Children

Ìý

Abstract:
This lecture will focus upon the field of mammalian neural stem cells and precursors from two perspectives. The first part of the lecture will focus on the mechanisms regulating self-renewal versus differentiation of embryonic neural precursors, and how this is perturbed in genetic syndromes that cause cognitive dysfunction. The second part will focus upon multipotent, neural crest-like dermal precursors (Skin-derived Precursors or SKPs) both with regard to their basic biology and their potential therapeutic use for treatment of the damaged nervous system.

About the Speaker:
Dr. Freda Miller is a cell and molecular developmental neurobiologist at the Hospital for Sick Children Research Institute, Professor at University of Toronto. She is the Canada Research Chair in Developmental Neurobiology, a Howard Hughes Medical Institute International Research Scholar, a Fellow of the Royal Society of Canada, and the Secretary of the American Society for Neurosciences. Dr. Miller has authored more than 120 scientific papers, reviews and book chapters and has 15 patents (issued and pending).


Dr. Miller is best known for her studies of neural stem cells and of neuronal growth, survival and apoptosis. Major findings from her lab have provided evidence that adult mammalian skin contains an accessible multipotent dermal stem cell that can generate peripheral neural cells, that the p75 neurotrophin receptor mediates apoptosis and axonal degeneration, that the p53 family members, p73 and p63 play a critical role in determining the life, death and degeneration of mammalian neurons, and that one way genetic disorders cause cognitive dysfunction is by perturbing embryonic neurogenesis.
Dr. Miller obtained her PhD in Medical Sciences from the University of Calgary and completed her postdoctoral training at the Scripps Research Foundation. She then held faculty positions at the University of Alberta and the Montreal Neurological Institute at Ï㽶ÊÓƵ prior to moving to her current position in 2002. Dr. Miller is also a founder of Aegera Therapeutics Inc., a Canadian biotechnology company.

Ìý

Ìý

Back to top